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As characterized by morphological assessment and terminal deoxynucleotidyltransferase-mediated dUTP
nick end labeling, Semliki Forest virus (SFV) infection of rat prostatic adenocarcinoma cells triggers an
apoptotic cell response. Cell death proceeded more rapidly following infection with the neurovirulent L10
strain of SFV than with the avirulent A7 strain. Overexpression of the antiapoptotic proto-oncogene bcl-2
allowed survival of cultures infected with either strain of virus. bcl-2 overexpression drastically reduced the
numbers of productively infected cells within the cultures. In situ hybridization for viral message-sense RNA
coupled with immunostaining for viral protein indicated that bcl-2 functions at an early stage of the virus life
cycle, at entry, pretranscriptional events or at transcription, to inhibit virus replication. Double-immunoflu-
orescent labeling for bcl-2 and viral glycoproteins revealed double-positive cells, demonstrating that with time,
this early block in replication can be overcome. These productively infected bcl-2-expressing cells do, with time,
undergo apoptosis. As a result of changing the balance between cell death and cell division by restricting
productive virus replication and delaying virus-induced cell death, bcl-2 expression led to the establishment of
chronically infected cell lines which could be passaged.
The avirulent A7 and virulent L10 strains of Semliki Forest
virus (SFV) display the same cell tropism in the central ner-
vous system (CNS) of 3- to 4-week-old mice, with neurons and
oligodendrocytes as the primary target cells (reference 26 and
our unpublished observations). However, the rates of spread of
these two strains within the CNS differ markedly. Following
intraperitoneal infection, the A7 strain fails to spread from its
perivascular sites of entry in the CNS and remains confined to
small foci scattered throughout the brain and spinal cord. Im-
munocompetent mice clear these foci within 2 weeks of infec-
tion. In contrast, the L10 strain, which also initiates CNS in-
fection as small perivascular foci, spreads rapidly throughout
the brain and spinal cord, resulting in acute encephalitis and
death of the mouse within 5 days (7).
In neonatal mice, SFV A7 spreads rapidly through the CNS
(7, 21). This change in spread correlates with the age-related
virulence characteristic of this strain of SFV (3, 23). SFV A7
infection of mice younger than 14 days results in 100% mor-
tality (21). This age-related susceptibility to SFV A7 cannot be
accounted for by maturing immune responses, since intraper-
itoneal inoculation of 3- to 4-week-old SCID mice results in a
persistent CNS infection which remains focal, with no dissem-
ination of the virus (1). Failure to clear virus from peripheral
tissues gives rise to a persistent viremia which continuously
seeds foci of infection in the CNS. Despite the accumulation of
significant levels of viral RNA and protein inside cells within
these foci, most mature CNS cells remain morphologically
intact. This is in marked contrast to the cytopathology ob-
served following SFV A7 infection of neonatal CNS cells in
vivo. Similar observations of age-related virulence have been
made with strains of Sindbis virus (10, 12).
Electron microscopic (EM) analyses have demonstrated
complete replication, including budding virions in the CNS of
neonatal mice infected with SFV A7. However, detailed EM
examination of A7-infected adult mouse brain has consistently
highlighted the absence of advanced stages of virus replication
in mature CNS cells (7, 23, 24). SFV A7-positive cells within
the developed CNS contain amorphous aggregates of viral
material termed viral core aggregates, but no assembled virions
have ever been observed. Within mature neurons, SFV A7
replication is restricted (7). In mature SCID or athymic nu/nu
mice, CNS neurons containing viral RNA can be detected for
the lifetime of the animal (1, 9).
Neurons are essential, irreplaceable components of the ma-
ture CNS. Since neuronal destruction constitutes irreversible
pathology, it is imperative that these highly specialized cells are
preserved. It has become clear that some virus infections can
induce programmed cell death. This has been illustrated with
members of the Herpesviridae (13), Parvoviridae (20), Retroviri-
dae (16, 19), Paramyxoviridae (6), Myxoviridae (11), and Picor-
naviridae (27) and with the prototype alphavirus, Sindbis virus
(18). A number of mammalian genes encoding antagonists of
programmed cell death have been identified. Among those
described, bcl-2 and bcl-x are known to be expressed in the
CNS. There is now evidence supporting a role for these genes
in promoting the survival of mature CNS neurons (14). It is
conceivable that by rendering mature CNS cells refractory to
virus-induced programmed cell death, genes of the bcl-2 family
may inadvertently allow neurons to act as reservoirs of viral
material.
Evidence to date suggests that developmentally regulated
host cell factors influence the outcome of SFV A7 infection in
vivo, in terms of cytopathology and virus propagation (7, 21).
Levine and coworkers reported that Sindbis virus induces ap-
optosis upon infection of rat prostatic adenocarcinoma cells
(AT3 cells) and that this virus-induced programmed cell death
can be prevented by overexpression of the cellular oncogene
bcl-2 (18). They demonstrated that bcl-2 expression led to the
establishment of a persistent infection. We have used the same
transfected AT3 cell lines to determine whether SFV infection
induces programmed cell death and to investigate in detail the
effect of overexpression of bcl-2 on the outcome of this infec-
tion.
* Corresponding author. Mailing address: Department of Veteri-
nary Pathology, University of Edinburgh, Summerhall, Edinburgh
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MATERIALS AND METHODS
Cells. AT3 cell lines transfected with the expression vector pZipNeo (AT3Neo
[4]) or the recombinant plasmid pZipBcl-2 (AT3Bcl-2 [18]) were obtained from
Marie Hardwick (Johns Hopkins University School of Medicine, Baltimore,
Md.). Cell cultures were maintained at 378C in supplemented RPMI. Cell via-
bility was assessed by trypan blue exclusion at serial time points after SFV
infection.
Viruses and plaque assays.Highly purified virus was used in these experiments
to avoid potential effects due to factors such as cytokines, for example, interfer-
ons, which could be present in crude virus preparations such as infected cell
supernatants. Infected culture supernatants were harvested 48 h postinfection
from BHK cell monolayers (infected at 0.01 PFU/ml) and clarified by centrifu-
gation at 7,000 rpm (48C) in a Sorval GSA rotor for 20 min. Virus was precip-
itated overnight (with 23 g of NaCl and 70 g of polyethylene glycol 8000 per liter)
from clarified culture supernatant maintained at 48C. Precipitated virus was
pelleted by centrifugation (as before) and resuspended in low-salt buffer (LSB;
0.15 M NaCl, 10 mM Tris [pH 7.4]). The virus suspension was loaded onto
preformed 20 to 70% sucrose gradients prepared in clear SW41 tubes and
banded by centrifugation for 2 h at 35,000 rpm in a Beckman ultracentrifuge at
48C. The virus band (formed in the middle of the gradient) was harvested, diluted
with LSB, and pelleted for 1 h at 35,000 rpm (48C) in an SW41 rotor. The virus
pellet was resuspended in a small volume of LSB. All plaque assays were per-
formed on 80% confluent BHK cell monolayers as described previously (7).
EM analyses. Cells were fixed in tissue culture flasks with 3% glutaraldehyde
in 0.1 M sodium cacodylate buffer (pH 7.3), scraped into the buffered fixative,
and pelleted by centrifugation at 1,0003 g for 5 min. Postfixation, the cell pellets
were immersed in 1% osmium tetroxide in 0.1 M sodium cacodylate buffer,
dehydrated through graded acetones (50 to 100%), and embedded in araldite
resin. Semithin (1-mm) sections were cut, stained with toluidine blue and borax,
and examined by light microscopy. Ultrathin sections for EM analysis were
stained with uranyl acetate and lead citrate and examined in a Philips EM400
transmission microscope.
Immunostains. Viral glycoproteins were detected by using a mixture of two
monospecific rabbit antipeptide antisera specific for SFV E1 and E2, followed by
a biotinylated goat anti-rabbit immunoglobulin G as secondary antibody (Vector
Laboratories), an avidin-biotin-peroxidase amplification step (Vector), and dia-
minobenzidine (Sigma) as the substrate. Cultures to be immunostained were
grown on poly-L-lysine-coated dual-chamber slides (Nunc) and fixed with 2%
paraformaldehyde-lysine-periodate fixative (PLP) or 4% phosphate-buffered for-
mal saline (PBS). Immunofluorescent staining for bcl-2 protein was performed
with an anti-human monoclonal antibody (MCA1279; Serotec) and a rhodamine
isothiocyanate-conjugated goat anti-mouse secondary antibody. Fluorescent
staining for viral glycoproteins was performed with the antipeptide antiserum
followed by a fluorescein isothiocyanate-conjugated anti-rabbit antiserum
(Dako).
TUNEL. PLP-fixed chamber slide cultures of AT3 cells were rinsed with PBS
and permeabilized with 0.3% Triton X-100 in PBS for 10 min. One specimen was
designated a positive control, equilibrated with DNase I buffer (30 mM Tris [pH
7.2], 140 mM sodium cacodylate, 4 mM MgCl2, 0.1 mM dithiothreitol) for 20
min, and then incubated in this buffer with DNase I (5 mg/ml) at 378C for 30 min.
After permeabilization, the remaining specimens were rinsed with PBS and
equilibrated with terminal deoxynucleotidyltransferase (TdT)-mediated dUTP
nick end-labeling (TUNEL) buffer (30 mM Tris [pH 7.2], 140 mM sodium
cacodylate, 1 mM cobalt chloride) for 20 min. All specimens were incubated with
TdT (0.3 U/ml), 20 mM digoxigenin (DIG)-11-dUTP, 30 mM Tris (pH 7.2), 140
mM sodium cacodylate, and 1 mM cobalt chloride for 2 h at 378C in a humidified
container. As a negative control, TdT enzyme was omitted from one reaction.
The reaction was terminated with 23 SSC (13 SSC is 0.15 M NaCl plus 0.15 M
sodium citrate) for 5 min at room temperature. Incorporated DIG-dUTP was
detected by enzyme-linked immunoassay, using an anti-DIG-alkaline phospha-
tase conjugate to catalyze a color reaction between 5-bromo-4-chloro-3-indolyl
phosphate (X-phosphate) and nitroblue tetrazolium salt, which deposits a blue
precipitate. Specimens were equilibrated with PBS, blocked with 3% normal goat
serum for 30 min, washed twice for 5 min each time in PBS–0.05% Tween 20, and
incubated with anti-DIG-alkaline phosphatase conjugate (Boehringer) diluted
1:100 in PBS with 1% normal goat serum. The specimens were then washed with
PBS (three times for 5 min each) and incubated with nitroblue tetrazolium salt
and X-phosphate solutions as detailed in the protocol for the Boehringer detec-
tion kit (catalog no. 1175 041).
Protein radiolabeling. Eighty percent confluent BHK cell monolayers were
either mock infected or infected at a multiplicity of infection (MOI) of 5 PFU/
cell with SFV A7. At 10, 22, 30, and 46 h postinfection, supernatant was har-
vested, clarified (centrifuged at 1,000 3 g for 5 min), and assayed for levels of
infectious virus. At each time point, monolayers were washed with PBS and
pulse-labeled for 1 h with 35S-Trans-label (ICN). Cell lysates were fractionated
on sodium dodecyl sulfate–12% polyacrylamide gels (15). Gels were soaked in
amplify (Amersham), dried under vacuum, and placed against photographic film
(GRI) for autoradiography.
In situ hybridization. In situ hybridization was performed with a 35S-labeled
riboprobe transcribed in vitro (using a riboprobe Gemini kit; Promega) from
HincII-linearized pGEM1-SFV (a kind gift from H. Garoff, Karolinska Institute,
Stockholm, Sweden). Transcription with T7 polymerase yielded a radiolabeled
negative-sense transcript complementary to the structural region of the SFV
genome. The radiolabeled transcript underwent alkaline hydrolysis in 0.04 M
NaHCO3 (30 min, 608C) prior to use. The in situ hybridization procedure was as
detailed previously (7, 8) except that the Triton X-100 and proteinase K pre-
treatment steps were omitted. At the end of the in situ hybridization procedure,
slides were dehydrated through 30 to 100% alcohol (containing 0.33 M ammo-
nium acetate) and placed in 0.3% H2O2 in methanol for 30 min prior to immu-
nostaining with the rabbit antipeptide antiserum as described above. The slides
were then dipped in LM-1 emulsion and stored in the dark at 48C. After 48 h,
slides were developed with Ilford ILfosol S developer as instructed by the man-
ufacturer.
RESULTS
SFV induces apoptosis. EM examination of SFV A7-in-
fected AT3Neo cells revealed morphological features of apo-
ptosis. Figure 1 displays EM images of an uninfected AT3Neo
cell and an AT3Neo cell 36 h after infection with SFV A7. The
nuclei of infected cells generally had condensed and margin-
alized chromatin, and the plasma membrane had lost the mi-
crovilli characteristic of uninfected AT3 cells and was folded
dramatically, creating cytoplasmic protrusions or blebs. The
cytoplasm of infected cells was shrunken and highly vacuolated
(Fig. 1B). TUNEL of SFV A7-infected AT3Neo cells revealed
that the nuclear DNA within these dying cells was fragmented,
another feature diagnostic of apoptosis (see Fig. 5E). Immu-
nostaining for viral glycoproteins confirmed that these cells
were infected. Interestingly, the blebbed cytoplasmic protru-
sions held particularly high concentrations of viral glycopro-
teins (see Fig. 5C and E).
Toluidine blue-stained 1-mm sections of pelleted uninfected
and infected AT3Neo cultures were examined by light micros-
copy. In Fig. 2, toluidine blue-stained sections of uninfected
and infected AT3Neo cells (36 h postinfection) are compared.
In general, relative to uninfected cells, cells in the infected
cultures were more rounded and had pale staining cytoplasm.
By 36 h, a large proportion of cells in the infected cultures
displayed a darkly stained margin of beaded chromatin edging
the nucleus, with the remainder of the nucleus lightly stained
relative to uninfected cells (Fig. 2B). Some blebbing cells were
evident in the infected cultures, and late stages of chromatin
condensation into apoptotic bodies was apparent in some cells
(Fig. 2B). In contrast, the nuclei and cytoplasm of uninfected
cells were relatively darkly stained with toluidine blue, and
chromatin was not marginalized (Fig. 2A).
bcl-2 slows SFV-induced programmed cell death. To deter-
mine whether the antiapoptotic gene bcl-2 can prevent SFV-
induced programmed cell death, the courses of viral infection
in AT3 cells expressing this gene (AT3Bcl-2 cells) and in con-
trol AT3Neo cells were compared. Cell viabilities within SFV
A7- or SFV L10-infected AT3Neo and AT3Bcl-2 cultures, and
parallel uninfected cultures, were compared by trypan blue
exclusion at serial time points after infection (MOI of 5 PFU/
cell). With time, infected cells became less adherent and most
of the cells displaying apoptotic features were floating in the
culture supernatant. Viability counts were therefore per-
formed on the total cell population by pooling monolayer cells
with cells in suspension in each sample. Parallel, triplicate
cultures were measured at each time point for each virus, and
the study was repeated at least three times with similar results.
The data presented are typical.
From 24 h, cell loss from SFV A7-infected AT3Neo cultures
was observed, and by 72 h, the cultures were completely de-
stroyed (Fig. 3A). In contrast, in the AT3Bcl-2 cultures, the
number of live cells in parallel infected and mock-infected
cultures increased up to 48 h (Fig. 3A). However, between 48
and 72 h, there was no increase in the number of live cells in
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SFV A7-infected AT3Bcl-2 cultures, although the parallel
mock-infected cultures doubled in viable cell number over the
same time period, reaching confluence at 1.4 3 106 cells per
35-mm-diameter plate by 72 h. This difference in live cell
number coincided with the appearance of trypan blue-perme-
able cells in the infected AT3Bcl-2 cultures. Even though some
cell death was evident in the infected AT3Bcl-2 cultures from
this time onward, the cultures were viable and could be sub-
cultured, giving rise to persistently infected cell lines.
AT3Neo cultures were destroyed more rapidly with SFV
L10 than with SFV A7 (Fig. 3B). By 24 h, there was significant
cell loss in the SFV L10-infected AT3Neo cultures relative to
infected AT3Bcl-2 cultures. The AT3Neo cultures were almost
totally destroyed by 36 h. However, as with SFV A7, bcl-2
expression promoted survival of SFV L10-infected AT3 cul-
tures (Fig. 3B). As in the SFV A7 time course, mock-infected
AT3Bcl-2 cultures outgrew SFV L10-infected AT3Bcl-2 cul-
tures, with L10 infection resulting in earlier divergence of these
growth curves.
bcl-2 expression slows virus production but allows increased
virus yield. To further compare the courses of infection in the
two cell lines, the titers of infectious virus in the culture su-
pernatants were determined. These are shown in Fig. 3C and D
for SFV A7 and L10, respectively, and are from the same
experiment as the cell counts. At 24 h, there were equal num-
bers of cells excluding trypan blue in the SFV A7-infected
AT3Neo and AT3Bcl-2 cultures (Fig. 3A); however, at this
time point, virus yields from the bcl-2-expressing cultures were
1,000-fold lower than those from the AT3Neo cultures (Fig.
3C). After 24 h, there was no further accumulation of extra-
cellular virus in the infected AT3Neo cultures, consistent with
the massive cell death occurring at this time. Extracellular virus
continued to accumulate in the supernatant of infected
AT3Bcl-2 cells, reaching levels similar to those in infected
AT3Neo cultures by 48 h and exceeding these levels by 72 h.
Initial virus yields from AT3 cells infected with SFV L10 were
also reduced by expression of bcl-2, and as seen with SFV A7,
the titer of SFV L10 virus in the supernatant of the AT3Neo
cultures started to fall after 24 h as viable cells in these cultures
were depleted (Fig. 3D and B). In contrast, the L10 virus titers
in the surviving AT3Bcl-2 cultures showed, as with A7 titers, a
steady increase with time (Fig. 3D).
Viral protein synthesis. To determine whether the differ-
ence in infectious virus titer in the supernatants of AT3Neo
and AT3Bcl-2 cells was due to a difference in virus replication
or virus release, virus protein synthesis was measured in the
cultures. Pulse-labeling of SFV A7-infected AT3Neo cultures
with 35S-labeled methionine and cysteine demonstrated that by
46 h, host cell protein synthesis had shut down. From 22 h, viral
proteins, particularly the viral capsid protein, could be clearly
detected against the low background of host cell proteins (Fig.
4). In contrast, levels of viral protein synthesis in the SFV
A7-infected AT3Bcl-2 cultures were too low to be discerned
against the continuing host cell protein synthesis. Between 10
and 30 h, taking the culture as a whole, more viral proteins
were synthesized in infected AT3Neo than in infected
AT3Bcl-2 cultures. This result is consistent with the virus titers
in the supernatant at these time points and indicates that virus
replication is greatly reduced in the AT3Bcl-2 cultures.
bcl-2 expression limits virus spread. The virus release and
pulse-labeling data demonstrate that bcl-2 expression slows the
progress of SFV infection at the level of the whole culture. To
examine events at the individual cell level, duplicate, parallel
SFV A7-infected AT3Neo and AT3Bcl-2 cultures were immu-
nostained to monitor expression of the viral glycoproteins (E1
and E2). Establishment of infection in both cell lines was slow.
FIG. 1. EM images. (A) Uninfected AT3Neo cell (M, microvilli). (B) SFV A7-infected AT3Neo cell at 36 h postinfection, with condensed and marginalized
chromatin (solid arrowheads), surface protrusions (blebs; B), and vacuolated cytoplasm (V).
VOL. 71, 1997 SFV AND PROGRAMMED CELL DEATH 1585
However, by 30 h there was a marked difference in the number
and distribution of virus antigen-positive cells in the cultures,
with the majority of cells in infected AT3Neo cultures positive
for viral glycoproteins but only relatively few cells positive in
infected AT3Bcl-2 cultures (Fig. 5A and B, respectively). By
42 h, the number of viral antigen-positive cells in SFV A7-
infected AT3Bcl-2 cultures had increased but still represented
a small proportion of the culture. SFV L10 infection of
AT3Bcl-2 cultures was similarly limited. Viral antigen-positive
cells were not evenly scattered throughout infected AT3Bcl-2
cultures but tended to appear as isolated groups of viral anti-
gen-positive cells within the largely viral antigen-negative
monolayer. Occasionally, blebbing cells were observed within
these limited areas of antigen-positive cells. Viral antigen-
positive blebbing cells were more common in SFV L10-in-
fected AT3Bcl-2 cultures. To eliminate the possibility that the
AT3Bcl-2 cells which were positive for viral glycoproteins were
cells which had lost bcl-2 expression, cultures were double
labeled for viral glycoproteins (Fig. 5H and I) and Bcl-2 pro-
tein (Fig. 5G and I). All cells in the culture, including those
positive for viral glycoproteins, expressed Bcl-2 (Fig. 5G and I;
Fig. 6A and B). The distribution of Bcl-2 was predominantly
perinuclear (Fig. 6C).
In situ hybridization for viral RNA. To investigate the stage
at which bcl-2 interfered with SFV infection, the number of
cells positive for viral RNA in SFV A7-infected AT3Bcl-2 and
AT3Neo cultures relative to the number expressing viral anti-
gen was determined by double labeling of the cultures, using in
situ hybridization for viral RNA and immunostaining for viral
glycoproteins. Cells which were positive for viral RNA and
glycoproteins were rare in both cell lines up to 12 h. However,
by 30 h, 98% of AT3Neo cells were positive for viral RNA,
compared to only 3% of AT3Bcl-2 cells (Table 1). The per-
centage of viral RNA-positive cells in AT3Bcl-2 cultures in-
creased to 17% by 42 h. As expected, in both cultures there
were more viral RNA-positive cells than viral protein-positive
cells. However, the proportions of viral RNA-positive to viral
protein-positive cells were similar in the two cultures at all time
points tested, indicating that there was no translational block
in viral replication in the AT3Bcl-2 cultures.
FIG. 2. Toluidine blue-stained 1-mm sections of uninfected AT3Neo cells
(A) and SFV A7-infected AT3Neo cells harvested from an infected monolayer at
24 h (B). Both preparations were stained for 1.5 min. Note that the nuclei and
cytoplasm of the infected cells are pale staining relative to the uninfected cells.
Many infected cells have beads of perinuclear staining (arrowheads) indicative of
marginalized chromatin. Cells in later stages of cell death with chromatin con-
densed into apoptotic bodies are also present (solid arrowheads).
FIG. 3. Cell viability (A and B), determined by trypan blue exclusion of
attached and floating cells, and accumulation of extracellular virus (C and D) in
the clarified supernatant of AT3 cultures infected with SFV A7 (A and C) or
SFV L10 (B and D). Each point represents the mean of three replicate cultures.
The error bars indicate the standard deviations of the mean. The experiment was
repeated at least three times with similar results. The drop in infectious virus titer
in the supernatants of the SFV A7- and L10-infected AT3Neo cultures after 24 h
postinfection represents virus instability at 378C. h, uninfected AT3Bcl-2 cells;
n, infected AT3Bcl-2 cells; F, infected AT3Neo cells.
1586 SCALLAN ET AL. J. VIROL.
TUNEL and immunostain analysis. To further characterize
the infection at the level of individual cells, cultures parallel to
those double labeled for viral protein and viral RNA were
double labeled for viral protein and TUNEL, and the number
of blebbing cells was recorded (Table 1). By 30 h, the percent-
ages of viral RNA-positive and viral glycoprotein-positive cells
in SFV A7-infected AT3Neo cultures were 98 and 68%, re-
spectively; 8% of the cells were TUNEL positive, and 5% were
blebbing. In bcl-2-expressing cultures at this time point, only
3% of cells were viral RNA positive and only 2% expressed
viral antigen. In both cultures, infected cells were rounded and
shrunken relative to uninfected cells. The degree of rounding
was proportional to the intensity of staining for viral glycopro-
tein. In SFV A7-infected AT3Bcl-2 cultures, TUNEL-positive
and blebbing cells were only rarely observed (Table 1); how-
ever, the cytoplasm of viral antigen-positive AT3Bcl-2 cells
often appeared to be particularly heavily laden with viral gly-
coproteins (Fig. 5B). It was striking that the proportion of cells
with TUNEL-positive nuclei in the infected AT3Neo mono-
layers did not rise above 10% even when rapid cell death was
ongoing in the culture, as seen, for example, at 42 h, when the
viability of the culture was only 35%. It seems likely that
fragmented nuclear DNA, in cells undergoing virus-induced
apoptosis, can be end labeled only during a relatively brief
phase in the apoptotic process. Likewise, the total number of
cells displaying the classical apoptotic blebbing morphology at
42 h amounted to less than 5% of the culture. This result is in
line with the execution phase of apoptosis being brief and the
condemned phase being variable, resulting in an asynchronous
transition through apoptosis (5).
Persistent infection. Monolayers from SFV A7- and SFV
L10-infected AT3Bcl-2 cultures were transferred, after 72 h of
infection, from the 35-mm-diameter dishes in which infections
were initiated to T175 tissue culture flasks. Prior to transfer,
the monolayers were washed with PBS, trypsinized briefly, and
harvested into fresh medium. The monolayers were subcul-
tured at weekly intervals. Levels of extracellular virus in the
supernatants of SFV A7- and SFV L10-infected cultures
reached 106 and 50 PFU/ml, respectively, at the end of the first
passage and 105 and 4 3 104 PFU/ml, respectively, at the end
of the second passage. The sparse remains of SFV L10-in-
fected AT3Neo cultures were also transferred to T25 flasks
with fresh medium. Colonies of cells were established from the
few surviving cells and grew to form a monolayer. This culture
of AT3Neo cells was subcultured in parallel to the persistently
infected cell lines. No virus was detected in the supernatant
from these cultures.
Cells from the first passage level of the AT3Bcl-2 culture
persistently infected with SFV A7 were cytospun onto Bio-
bond-coated glass slides, and in situ hybridization for viral
RNA, immunostaining for viral glycoprotein, and TUNEL
staining for DNA fragmentation were carried out (Table 1 and
Fig. 5F). A small proportion (5%) of the AT3Bcl-2 cells were
viral RNA positive, and many of these cells (3% of the total
cell population) expressed viral glycoprotein. A small propor-
tion (0.8%) of cells were TUNEL positive, and 0.2% of the
cells displayed a blebbing morphology (Table 1). All cells in
the culture, including those that were viral RNA and viral
glycoprotein positive, expressed Bcl-2. It therefore appears
that bcl-2 can convert a normally lytic SFV infection to a
persistent infection. The persistently infected culture exists as
a chronically infected cell population in which the majority of
cells are not undergoing productive viral replication. The in-
fectious virus released into the culture supernatant originates
from a subpopulation of productively infected cells. Individual
productively infected cells within the persistently infected cul-
ture eventually die.
DISCUSSION
We have demonstrated that SFV infection induces morpho-
logical alterations in AT3Neo cells characteristic of apoptosis,
including condensed and fragmented chromatin which is mar-
ginalized to the periphery of the nucleus and the replacement
of the normal fine villus folds of a healthy cell membrane with
dramatic bulges containing blebbing cytoplasm. The protrud-
ing blebs often contain high concentrations of viral glycopro-
teins. These observations are consistent with studies on Sindbis
virus (18, 25).
Apoptosis in AT3Neo cultures proceeded more slowly with
SFV A7 than with SFV L10. This result is consistent with the
observation that SFV L10 displays greater cytopathogenicity
for neuroblastoma cells than SFV A7 (2). AT3 cells overex-
pressing bcl-2 displayed a markedly different response to SFV
infection. Monolayers of AT3Bcl-2 cells survived infection with
both the A7 and L10 strains of SFV, and persistently infected
cell lines could be readily maintained after infection of
AT3Bcl-2 cultures with both strains of virus. Overexpression of
bcl-2 has been shown to protect AT3 cell cultures from the
lethal effects of infection with avirulent but not neurovirulent
strains of Sindbis virus (18, 28). Studies with recombinant
Sindbis viruses identified a single amino acid change (Gln in
place of His at position 55 of the E2 glycoprotein) which
conferred both neurovirulence and the ability to kill cells ex-
pressing bcl-2 (28). Our studies suggest that the neurovirulence
determinants which distinguish the A7 and L10 strains of SFV
are unrelated to responsiveness to bcl-2. Similarly, neuroviru-
lent strains of influenza virus cannot overcome the protective
effect of bcl-2 (11).
The survival of infected AT3Bcl-2 cultures resulted in levels
of released virus accumulating to eventually exceed the maxi-
mum level of virus produced before death of the AT3Neo
cultures. This finding illustrates the advantage that an apopto-
tic cell response can provide to a multicellular host by limiting
virus yields. However, in vivo, by counteracting virus-encoded
death signals, host-encoded antiapoptotic genes may be impor-
tant to sustain the life of irreplaceable cells, perhaps long
enough to enable non-cytopathic-immune mechanisms to clear
FIG. 4. Protein synthesis in SFV A7-infected AT3Neo and AT3Bcl-2 cells.
Cell monolayers were either mock infected (lanes M) or infected with 5 PFU of
SFV A7 per cell and then pulse-labeled for 1 h with 35S-Trans-label (ICN) at 10,
22, 30, and 46 h postinfection. Cell lysates were fractionated on sodium dodecyl
sulfate–12% polyacrylamide gels. The viral capsid protein (C) is indicated. In the
AT3Neo cultures, this is first clearly apparent at 22 h. By 42 h, there is shutoff of
host cell protein synthesis in these cultures. No capsid protein was detectable in
the AT3Bcl-2 cultures, even at 46 h.
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FIG. 5. Double-labeling studies of SFV-infected AT3Neo and AT3Bcl-2 cultures. (A to E) Immunostaining (brown) for the viral E1 and E2 envelope glycoproteins
and TUNEL labeling (blue-black) for DNA fragmentation at 30 h after infection with SFV A7; (F) immunostaining (brown) for viral E1 and E2 proteins and in situ
hybridization (silver grains) for viral RNA performed on cells from an AT3Bcl-2 culture persistently infected with SFV A7; (G to I) double immunostaining for Bcl-2
(red) and viral E1 and E2 proteins (green). (A, C, and E) AT3Neo cultures; (B and D) parallel AT3Bcl-2 cultures 30 h after SFV A7 infection. By 30 h, many cells
in the AT3Neo cultures have been lost from the monolayer (A) and the majority of cells remaining on the monolayer are positive for viral glycoproteins (A and C).
Most of the cells in the AT3Bcl-2 cultures remained on the monolayer, and only a small proportion of these (Table 1) stained positive for viral E1 and E2 proteins
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the infection. Noncytopathic, antibody-mediated clearance of
alphavirus from CNS neurons has been demonstrated (17).
The explanation for the survival of the bcl-2-expressing cul-
tures may be complex. If we exclude the unlikely but uninves-
tigated possibility that the two clones of AT3 cells differ phe-
notypically in factors other than bcl-2 which affect virus
replication and/or induction of cell death, then at least two
aspects are clear. First, as demonstrated by the pulse-labeling,
immunostaining, and in situ hybridization studies, overexpres-
sion of bcl-2 affects virus entry or an early stage in virus rep-
lication, which results in very few cells in these cultures under-
going productive virus replication. There was a profound
difference in the number of productively infected cells within
monolayer cultures of AT3Neo relative to AT3Bcl-2 cells.
However, there was no difference between these cultures in the
proportion of viral glycoprotein-positive cells relative to viral
mRNA-positive cells. This result indicates that the low number
of productively infected AT3Bcl-2 cells does not result from a
block in viral translation in the remaining majority of cells.
Neither is bcl-2 likely to be acting posttranslationally in these
cells to limit virus assembly or release and therefore spread of
infection in the culture. The extracellular virus released from
the AT3Bcl-2 cultures represents an efficient yield from the
relatively small number of virus glycoprotein-positive cells, and
based on plaque size, this virus plaques with an efficiency equal
to that of the purified input virus. The titers of infectious virus
in the supernatants of both the SFV A7- and L10-infected
AT3Bcl-2 cultures were sufficient at infection (MOI 5 5) and
at 24 h and 48 h to infect all of the cells in the culture, yet only
a relatively small proportion showed evidence of virus replica-
tion as determined by positivity for viral RNA (Table 1): at
42 h, 17% for SFV A7 in the AT3Bcl-2 cultures, relative to
95% in the AT3Neo cultures. Our data therefore indicate that
bcl-2 functions early in the virus life cycle to inhibit virus entry
or early stages of virus replication. This inhibition is prior to, or
at the stage of, transcription of the subgenomic RNA or rep-
lication of the genomic RNA, since the probe used in our in
situ hybridization reproducibly detects replicating levels of
both of these species of viral RNA. However, the in situ hy-
bridization is unlikely to be able to detect single copies of viral
RNA, and we therefore cannot distinguish between the possi-
bilities that the majority of the AT3Bcl-2 cells were infected
but could not undergo the early stages of viral replication or
that intact viral RNA did not enter the cytoplasm of these cells.
Similarly, bcl-2 expression has been reported to restrict influ-
enza virus infection in transfected Madin-Darby canine kidney
cell cultures (22). Bcl-2 therefore results in an early, entry-
level, pretranscriptional or transcriptional block in SFV repli-
cation, which at least in some cells, or perhaps in all cells with
time, can be overcome.
The second effect of bcl-2 overexpression, which is clear and
demonstrated by the culture survival curves (Fig. 3) and the
TUNEL staining, is that cell death in the bcl-2-expressing cul-
tures is delayed. This might be due to only a few cells being
infected and triggered to die, although it is not clear how bcl-2
FIG. 6. Immunofluorescent labeling of AT3Bcl-2 cultures for Bcl-2 expres-
sion. As can be seen by comparison of the phase-contrast (A) and fluorescent (B)
images of the same field, all cells in the AT3Bcl-2 culture stained strongly
positive for Bcl-2. The staining was predominantly perinuclear (C).
TABLE 1. Percentages of cells in SFV A7-infected AT3Neo and
AT3Bcl-2 cultures which were viral RNA positive, viral antigen
positive, TUNEL positive, or displayed cytoplasmic blebs
Cell culturea
% Positive cells
Virus
RNA
Virus
antigen TUNEL
Blebbing
cells
30 h
Neo (Un) 0 0 2 0
Neo A7(74) 98 68 8 5
Bcl-2 (Un) 0 0 0.2 0
Bcl-2 A7(74) 3 2 0.2 0.2
42 h
Neo (Un) 0 0 0 0
Neo A7(74) 95 81 8 4
Bcl-2 (Un) 0 0 0 0
Bcl-2 A7(74) 17 14 0.3 0
PI
Bcl-2 A7(74) 5 3 0.8 0.2
a Un, uninfected cells; PI, cells from the first passage level of the persistently
infected cell line.
(B and D), some strongly (arrowhead). Several TUNEL-positive nuclei were observed in the infected AT3Neo cultures (arrowheads in panels A and C). The blebbing
processes of these cells contained high levels of viral glycoproteins (E). TUNEL-positive cells were only rarely observed in the AT3Bcl-2 cultures (none are present
in the fields shown). (F) AT3Bcl-2 cells double labeled for viral RNA (silver grains) and viral glycoproteins (brown immunostain) from the first passage level of a culture
persistently infected with SFV A7. The nucleus (N) is unstained. (G to I) Double-immunofluorescent staining of SFV L10-infected AT3Bcl-2 cultures at 72 h,
demonstrating that cells staining positive for viral E1 and E2 glycoproteins (green) have not lost their ability to express Bcl-2 (red). All cells in the culture were positive
for Bcl-2. (I) Double exposure of fluorescence from Bcl-2 and viral antigen staining.
VOL. 71, 1997 SFV AND PROGRAMMED CELL DEATH 1589
expression might affect virus entry. Alternatively, and perhaps
more likely, many cells could be nonproductively infected. In
this case, the viral trigger for induction of cell death must be
downstream of the bcl-2-induced block in virus replication.
Nevertheless, some cells in the AT3Bcl-2 cultures are produc-
tively infected. Whether bcl-2 delays apoptosis in these cells is
difficult to ascertain without knowing the time of infection and
death of individual cells. In the SFV A7-infected AT3Bcl-2
cultures by 42 h, 17 and 14% of cells were virus RNA positive
and virus protein positive, respectively (Table 1), but TUNEL-
positive cells were rarely observed, and no difference in the
growth curves of the infected and mock-infected cells was
observed at this or earlier time points (Fig. 3). Furthermore,
some of the cells in the AT3Bcl-2 cultures which were virus
protein positive were more strongly positive than infected
AT3Neo cells (Fig. 5B). These unusually high levels of viral
proteins could result from prolonged cell survival. bcl-2 expres-
sion therefore appears not only to inhibit an early stage of virus
replication but also to buffer the death stimulus associated with
SFV infection, slowing the rate of cell death rather than pre-
venting it. In conclusion, bcl-2 restricts SFV replication by
inhibiting an early stage of the virus replication cycle and
appears to prolong survival of productively infected cells. By
altering the balance between productive virus replication-in-
duced cell death and cell division, bcl-2 expression promotes
survival of the culture as a chronically infected cell population.
ACKNOWLEDGMENTS
We are grateful to Sylvia Shaw, Heather Dyson, and Yvonne Trozer
for excellent technical support.
This work was supported by a grant from the UK Medical Research
Council.
REFERENCES
1. Amor, S., M. F. Scallan, M. M. Morris, H. Dyson, and J. K. Fazakerley. 1996.
Role of immune responses in protection and pathogenesis during Semliki
Forest virus encephalitis. J. Gen. Virol. 77:281–291.
2. Atkins, G. J. 1983. The avirulent A7 strain of Semliki Forest virus has
reduced cytopathogenicity for neuroblastoma cells compared to the virulent
L10 strain. J. Gen. Virol. 64:1401–1404.
3. Bradish, C. J., K. Allner, and H. B. Maber. 1971. The virulence of original
and derived strains of Semliki Forest virus for mice, guinea-pigs and rabbits.
J. Gen. Virol. 12:141–160.
4. Cepko, C. L., B. E. Roberts, and R. C. Mulligan. 1984. Construction and
applications of a highly transmissible murine retrovirus shuttle vector. Cell
37:1053–1062.
5. Earnshaw, W. C. 1995. Nuclear changes in apoptosis. Curr. Opin. Cell Biol.
7:337–343.
6. Esolen, L. M., S. W. Park, J. M. Hardwick, and D. E. Griffin. 1995. Apoptosis
as a cause of death in measles virus-infected cells. J. Virol. 69:3955–3958.
7. Fazakerley, J. K., S. Pathak, M. Scallan, S. Amor, and H. Dyson. 1993.
Replication of the A7(74) strain of Semliki Forest virus is restricted in
neurones. Virology 195:627–637.
8. Fazakerley, J. K., P. Southern, F. Bloom, and M. Buchmeier. 1991. High
resolution in situ hybridization to determine the cellular distribution of
lymphocytic choriomeningitis virus RNA in the tissues of persistently in-
fected mice: relevance to arenavirus disease and mechanisms of viral persis-
tence. J. Gen. Virol. 72:1611–1625.
9. Fazakerley, J. K., and H. E. Webb. 1987. Semliki Forest virus-induced,
immune-mediated demyelination: adoptive transfer studies and viral persis-
tence in nude mice. J. Gen. Virol. 68:377–385.
10. Griffin, D. E., B. Levine, W. R. Tyor, P. C. Tucker, and J. M. Hardwick. 1994.
Age-dependent susceptibility to fatal encephalitis: alphavirus infection of
neurons. Arch. Virol. 9:31–39.
11. Hinshaw, V. S., C. W. Olsen, N. Dybdahl-Sissoko, and D. Evans. 1994.
Apoptosis: a mechanism of cell killing by influenza A and B viruses. J. Virol.
68:3667–3673.
12. Johnson, R. T., H. F. McFarland, and S. E. Levy. 1972. Age-dependent
resistance to viral encephalitis: studies of infections due to Sindbis virus in
mice. J. Infect. Dis. 125:257–262.
13. Kawanishi, M. 1993. Epstein-Barr virus induces fragmentation of chromo-
somal DNA during lytic infection. J. Virol. 67:7654–7658.
14. Krajewski, S., J. K. Mai, M. Krajewski, M. Sikorska, M. Mossakowski, and
J. C. Reed. 1995. Upregulation of Bax protein levels in neurons following
cerebral ischemia. J. Neurosci. 15:6364–6376.
15. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of
the head of bacteriophage T4. Nature 227:680–685.
16. Laurent-Crawford, A. G., B. Krust, S. Muller, Y. Riviere, M.-A. Rey-Cullie,
J.-M. Bechet, L. Montagnier, and A. G. Hovanessian. 1991. The cytopathic
effect of HIV is associated with apoptosis. Virology 185:829–839.
17. Levine, B., J. M. Hardwick, B. D. Trapp, T. O. Crawford, R. C. Bollinger, and
D. E. Griffin. 1991. Antibody-mediated clearance of alphavirus infection
from neurons. Science 254:856–860.
18. Levine, B., Q. Huang, J. T. Isaacs, J. C. Reed, D. E. Griffin, and J. M.
Hardwick. 1993. Conversion of lytic to persistent alphavirus infection by the
bcl-2 cellular oncogene. Nature 361:739–742.
19. Meyaard, L., S. A. Otto, R. R. Jonker, M. J. Miinster, R. P. M. Keet, and F.
Miedema. 1992. Programmed death of T cells in HIV-1 infection. Science
257:217–219.
20. Morey, A. L., D. J. P. Ferguson, and K. A. Flemming. 1993. Ultrastructural
features of fetal erythroid precursors infected with parvovirus B19 in vitro:
evidence of cell death by apoptosis. J. Pathol. 169:213–220.
21. Oliver, K. R., M. F. Scallan, H. Dyson, and J. K. Fazakerley. Susceptibility
to a neurotropic virus and its changing distribution in the developing brain is
a function of CNS maturity. J. Neurovirol., in press.
22. Olsen, C. W., J. C. Kehren, N. R. Dybdahl-Sissoko, and V. S. Hinshaw. 1996.
bcl-2 alters influenza virus yield, spread, and hemagglutinin glycosylation.
J. Virol. 70:663–666.
23. Pathak, S., and H. E. Webb. 1978. An electron-microscopic study of avirulent
and virulent Semliki forest virus in the brains of different ages of mice.
J. Neurol. Sci. 39:199–211.
24. Pathak, S., H. E. Webb, S. W. Oaten, and S. Bateman. 1976. An electron-
microscopic study of the development of virulent and avirulent strains of
Semliki Forest virus in mouse brain. J. Neurol. Sci. 28:289–300.
25. Rosen, A., L. Casciola-Rosen, and J. Ahearn. 1995. Novel packages of viral
and self-antigens are generated during apoptosis. J. Exp. Med. 181:1557–
1561.
26. Smyth, J. M. B., B. J. Sheahan, and G. J. Atkins. 1990. Multiplication of
virulent and demyelinating Semliki Forest virus in the mouse central nervous
system: consequences in BALB/c and SJL mice. J. Gen. Virol. 71:2575–2583.
27. Tolskaya, E. A., L. I. Romanova, M. S. Kolesnikova, T. A. Ivasnikova, E. A.
Smirnova, N. T. Raikhlin, and V. I. Agol. 1995. Apoptosis-inducing and
apoptosis-preventing functions of poliovirus. J. Virol. 69:1181–1189.
28. Ubol, S., P. C. Tucker, D. E. Griffin, and J. M. Hardwick. 1994. Neuroviru-
lent strains of alphavirus induce apoptosis in bcl-2 expressing cells; role of a
single amino acid change in the E2 glycoprotein. Proc. Natl. Acad. Sci. USA
91:5202–5206.
1590 SCALLAN ET AL. J. VIROL.
